The bla NDM-1 gene encodes a carbapenemase that confers resistance to almost all ␤-lactams, including last-resort carbapenems. This is increasingly reported worldwide in nosocomial and community-acquired Gram-negative bacteria. Acinetobacter baumannii is an important opportunistic pathogen that is considered an intermediate reservoir for the bla NDM-1 gene. In this species, the bla NDM-1 gene is located within the Tn125 composite transposon. The mechanism driving the mobility of Tn125 has not yet been elucidated. Here we experimentally demonstrated the transposition of Tn125 in A. baumannii. Systematic 3-bp duplication of the target site, being the signature of transposition, was evidenced. The target site consensus sequence for Tn125 transposition was found to be GC enriched at the duplicated 3 bp and AT rich in the vicinity. Transposition frequency was not influenced by temperature changes or by exposure to subinhibitory concentrations of various antibiotics. This work is the first direct evidence of the functionality of a composite transposon in A. baumannii. It provides a mechanistic clue for the dissemination of the bla NDM-1 gene in Acinetobacter spp. and subsequently among Enterobacteriaceae.
C
arbapenemases are enzymes hydrolyzing most ␤-lactams, including penicillins, cephalosporins, and carbapenems. During the last decade, they have been increasingly reported worldwide in Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae. The spread of carbapenemases is of utmost importance for medicine, since carbapenems are last-resort antibiotics for treating the most severe and hospital-acquired infections. The class B New Delhi metallo-␤-lactamase (NDM-1) is a broad-spectrum ␤-lactamase, hydrolyzing penicillins, cephalosporins, and carbapenems (1) . NDM-1 was first identified in a Klebsiella pneumoniae isolate from a patient previously hospitalized in India in 2008 (2) . Since then, it has been found mostly in Enterobacteriaceae and A. baumannii and to a lesser extend in P. aeruginosa (1, 3) . The origin of the bla NDM-1 resistance gene and the mechanism(s) driving its mobility remains unknown. However, a current hypothesis suggests that the bla NDM-1 gene originates from an environmental bacterial progenitor species and that A. baumannii is an intermediate reservoir for the bla NDM-1 gene (4) .
A. baumannii is an opportunistic human pathogen and a common cause of sepsis, pneumonia, urinary tract infection, and primary bacteremia. Multidrug-resistant A. baumannii isolates are of great concern (5, 6) . In Acinetobacter spp., the bla NDM-1 gene is embedded in transposon Tn125 (4, 7, 8) . Tn125 is a 10,099-bp composite transposon bracketed by two copies of the insertion sequence (IS) ISAba125 orientated in the same direction (Fig. 1A ) (4, 7, 8) . The 1,087-bp ISAba125 element belongs to the IS30 family and encodes a 322-amino-acid-long DDE-type transposase surrounded by imperfect terminal inverted repeat sequences (IRR [inverted repeat right] and IRL [inverted repeat left], sharing 20/26 nucleotide identity) (9, 10) . The ble MBL gene, which encodes a 121-amino-acid-long protein conferring resistance to bleomycin, a glycopeptide antibiotic used as an antitumor agent, is located downstream of the bla NDM-1 gene (11) . In addition, Tn125 comprises six genes encoding putative proteins (iso, tat, dct, groES, groEL, and ⌬pac [a truncated phospholipid acetyltransferase gene]), the ISCR21 element, and the putative oriIS sequence that defines the origin of replication of ISCR21 (7, 8) . ISCR elements are peculiar ISs belonging to the IS91 family, likely mobilizing genes located at their left-hand extremity by a rolling-circle transposition process (12, 13) .
Current observations suggest that the bla NDM-1 gene originates from an unknown environmental bacterial progenitor species and is integrated into the chromosome of Acinetobacter spp. The bla NDM-1 -bearing Tn125 transposon was likely subsequently built from such Acinetobacter spp. and then transferred onto broadhost-range plasmids, followed by horizontal transfer to Enterobacteriaceae and P. aeruginosa. This hypothesis is supported by a series of genetic features (4, 5), as follows. (i) The bla NDM-1 gene displays a higher GC percentage (62%) than that of the genome of Acinetobacter spp. (38% to 42%), arguing in favor of a phylogenetic distance between the progenitor species and Acinetobacter spp. (ii) ISCR21 may have mobilized a fragment encompassing the bla NDM-1 gene that displays a similar GC percentage from an unknown bacterial progenitor. (iii) ISAba125 has also been identified in Acinetobacter species isolates without physical association with the bla NDM-1 gene and shows a low GC content of 37%, consistent with a possible Acinetobacter species origin (4, 5) .
A critical step in the dissemination process of the bla NDM-1 gene is the mobility of the Tn125 transposon in Acinetobacter spp. According to its genetic structure, it was presumed that Tn125 can move through transposition. Transposition is a catalytic process, driven by an element-specific transposase. During this process, the transposase generates a short direct repeat flanking the transposon in the target DNA, corresponding to a signature of the transposition event (10) . Alternative mechanisms for Tn125 transfer might involve nonhomologous recombination or cointegration. Here, we show that the Tn125 transposon can efficiently transpose in A. baumannii and that the transposition frequency is not influenced by temperature changes or antibiotic pressure.
MATERIALS AND METHODS

Strains.
Transposition experiments were performed in A. baumannii CIP70.10 and Ab17978 (recA::Km) (14) reference strains. Plasmids were constructed in Escherichia coli TOP10 (Invitrogen).
Plasmid construction. For pTOPO-Tn125, the Tn125 transposon was amplified from A. baumannii strain JH (8) together with 98 bp and 99 bp of the flanking genomic sequences present in upstream and downstream Tn125, respectively, with primers JHorfTn125-HindIII-F (5=-gatgat aagcttTCAGCAATAAATTTGTCACCAGC-3=) and JHorfTn125-XbaI-R (5=-gatgattctagaCAAGCTGCTCAAGTTAAAGATCG-3=) (the HindIII and XbaI restriction sites are underlined, and the uppercase letters correspond to the open reading frame [ORF] identified in strain JH). This amplicon was subcloned into the HindIII and XbaI restriction sites of the pCR-BluntII-TOPO plasmid (Invitrogen). The integrity of both ISAba125 elements and of bla NDM-1 was confirmed by sequencing. pTOPO-zeodel-Tn125 was derived from pTOPO-Tn125, in which a frameshift in the zeocin resistance gene was generated by digestion at the unique FseI site, blunting, and self-ligation. The resulting zeocin resistance protein lacks the 32 C-terminal amino acids. For the pTOPO-shuttle-Tn125 plasmid, the A. baumannii-specific origin of replication was amplified from pWH1266 (a kind gift from P. Higgins) and subcloned into pTOPO-Tn125 between the BsrGI and HindIII restriction sites. Plasmid pTOPO-shuttle-Tn125 replicates in E. coli, from which it can be selected with 50 g/ml zeocin, 100 g/ml ampicillin, 25 g/ml kanamycin, or 0.5 g/ml imipenem (IPM), in A. baumannii CIP70.10, from which it can be selected with 25 g/ml kanamycin, 200 g/ml zeocin, or 1 g/ml IPM, and finally in A. baumannii Ab17978 recA::Km, from which it can be selected with 10 g/ml zeocin or 1 g/ml IPM. Full sequences of the Tn125 plasmids are available upon request.
Transposition assays. One-hundred-nanogram amounts of pTOPOTn125 or pTOPO-zeodel-Tn125 suicide plasmids were electroporated into 25 l of electrocompetent A. baumannii cells with a MicroPulser (Bio-Rad). The bacteria were resuspended in 2 ml LB and incubated for 1 h 30 min at 37°C with agitation. A total of 100 l was plated onto LB agar plates supplemented with 1 g/ml IPM to select the transposition events. The transformation efficiency was determined with the highly similar pTOPO-shuttle-Tn125 plasmid (replicating in A. baumannii), which was electroporated and processed in parallel to the suicide plasmids. The transposition frequencies were calculated by dividing the number of transposition events by the number of transformed cells. Experiments were done in triplicate. The same procedure was used to address the effect antibiotics has on transposition, but cells were incubated for 3 h at 37°C after electroporation with the following antibiotics: the glycopeptide bleomycin (1 g/ml and 5 g/ml) (Molekula) or zeocin (4 g/ml and 8 g/ ml), the fluoroquinolone ciprofloxacin (0.05 g/ml and 1 g/ml) (SigmaAldrich), the aminoglycoside kanamycin (1.5 g/ml and 3 g/ml) (Roth; ThermoFisher Scientific), and the carbapenem imipenem (0.125 g/ml and 0.25 g/ml) (Mylan). The MIC of bleomycin for Tn125-containing CIP70.10 was 10 g/ml, while it was Ͻ1 g/ml for the parental CIP70.10 strain.
Molecular characterization of transposition events. The presence of the full-length Tn125 was confirmed by the amplification in 5= of a 925-bp fragment spanning from ISAba125 to bla NDM-1 with primers 125-F (5=-ACACCATTAGAGAAATTTGC-3=) and NDM-R (5=-CGGAATGGC TCATCACGATC-3=) and in 3= of a 1,326-bp fragment spanning from ⌬pac to ISAba125 with primers dpac-F (5=-CAACTGTGAGTCCTTTAC TGAC-3=) and 125-R (5=-GCAAATTTCTCTAATGGTGT-3=). The integration sites of the transposition events were characterized by shotgun cloning. Total genomic DNA was digested with EcoRV and ligated into the EcoRV-digested and dephosphorylated pBSKS-kanR vector. The libraries were electroporated into E. coli TOP10 and plated onto LB agar containing 1 mg/liter IPM to select for bla NDM-1 -positive clones, which were sequenced with the primer IS125tpase_NORF-R (5=-CTCACGATA GATCGTACTAGG-3=) to identify the genomic sequence upstream of Tn125. For each transposition event, a primer was designed to amplify a fragment spanning from the 3= end of Tn125 to the genomic sequence downstream of Tn125. These PCR amplicons were sequenced with primer IS125tpase-CORF-F (5=-CATGTCACTGAATACTCGTCC-3=).
Determination of the AT and GC contents and pictogram of the target site consensus. For the 27 transposition events characterized, the relative frequencies of each A and T, and G and C, for the region extending from 50 nucleotides upstream to 50 nucleotides downstream from the duplicated 3-bp target site were calculated and plotted onto a graph. The pictures of the relative frequencies of the bases at each position were generated with the Pictogram program (http://genes.mit.edu/pictogram .html).
Detection of ISAba125 in Acinetobacter species strains. Strains were screened by PCR with primers Tn125-F (5=-TGTATATTTCTGTGAC CCAC-3=) and Tn125-R (5=-GAAGGCGAATTCAAACATGAGGTGC-3=). A 255-bp product was amplified in the presence of ISAba125. (8) . Four imipenem-resistant clones, two in A. baumannii CIP70.10 and two in A. baumannii Ab17978, were stepwise characterized as follows. First, they were tested for the loss of kanamycin and zeocin resistance markers, confirming that the donor plasmid did not integrate into the genome. Second, the presence of the full-length transposon Tn125 and the absence of the flanking sequences present in the donor plasmid were confirmed by PCR. Third, the genomic sequences flanking Tn125 were characterized in order to map the transposition sites and analyze the target site duplication. As shown in Fig. 1B , for each of the four studied clones, the entire Tn125 transposed into distinct loci of the A. baumannii chromosome. A 3-bp target site duplication was present in each case. Transposition of Tn125 conferred resistance to cephalosporins and carbapenems, with MIC values of ceftazidime, imipenem, and meropenem being Ͼ256, Ͼ32, and Ͼ32 g/ml, respectively.
RESULTS
Transposition of Tn125 in
Transposition frequencies. The transposition frequencies measured with pTOPO-Tn125 and pTOPO-zeodel-Tn125 as donors were 4.5 ϫ 10 Ϫ4 (Ϯ0.5 ϫ 10 Ϫ4 ) and 5.7 ϫ 10 Ϫ4 (Ϯ0.9 ϫ 10 Ϫ4 ) per transformed cell, respectively (Table 1 , experiment 1). The frequencies with both donor plasmids were in the same range, excluding the potential influence of the zeocin marker gene, which confers resistance to the same class of molecules (bleomycin) as the ble MBL gene. Since the source of dissemination of the bla NDM-1 gene is likely the environment, in particularly in Asia (15, 16) , where a variety of antibiotics has been widely identified (17, 18) and where temperature changes might influence the transposition frequency (19, 20) , corresponding experiments were conducted. Incubation for 3 h with 1 or 5 g/ml bleomycin, a glycopeptide antibiotic used as an antitumor agent, did not influence the transposition rate of Tn125 (Table 1 , experiment 2). Similarly, the transposition rate was not influenced by incubation for 3 h at different temperatures (25°C, 30°C, 37°C, or 44°C) or by the presence of subinhibitory concentrations of structurally nonrelated antibiotics, such as fluoroquinolone (ciprofloxacin), aminoglycoside (kanamycin), glycopeptide (zeocin), and carbapenem (imipenem) (data not shown).
Target site specificity. In order to determine a consensus target site for Tn125 transposition, 25 additional independent transposition events, in 25 independent isolates, were characterized in A. baumannii CIP70.10. Among the transposition events, 19 occurred within open reading frames (ORFs), 8 in direct orientation and 11 in reverse orientation compared to the disrupted ORF, and 8 outside of ORFs. For each transposition event, a systematic 3-bp duplication of the target site was evidenced ( Fig. 2A) . To further characterize the features of the target site, the surrounding genomic sequences of the 27 transposition events were aligned, from 50 bp upstream up to 50 bp downstream of Tn125. The mean AT content for the regions distal to the duplicated target site, from Ϫ50 to Ϫ4 bp and from ϩ4 to ϩ50 bp relative to it, was 72% on both sides (Fig. 2B, upper graph) . Around the duplicated target site, the AT content increased, with 100% at positions Ϫ3 and ϩ3 and 83% to 90% at positions Ϫ2, Ϫ1, ϩ1, and ϩ2 (Fig. 2B, lower  graph) . By analysis of the nucleotide composition, the Ϫ3 position was found to be predominantly an A (69%), and the ϩ3 position was found to be predominantly a T (72%) (Fig. 2C) . At the duplicated target site positions, named here c1, c2, and c3, the AT content was lower (38% to 62%) (Fig. 2B, lower graph) . At c1, A, T, C, and G were equally represented (24% to 28%), while G was underrepresented at c2 (10% versus 38%, 24%, and 28% for A, T, and C, respectively) and predominant at c3 (48% versus 21%, 17%, and 14% for A, T, and C, respectively) (Fig. 2C) . Further analysis of sequences flanking 74 ISAba125 elements retrieved from GenBank confirmed the consensus derived from the analysis of Tn125 transposition events (Fig. 2D ). In conclusion, the target site specificity of Tn125 was driven mainly both by the 3 bp surrounding the duplicated target site, being AT rich and reaching 96% to 99% A or T at positions Ϫ3 and ϩ3, and by the duplicated 3-bp target site itself, which was GC enriched, with a strong bias for nucleotide G at the position c3. Distribution of ISAba125 in Acinetobacter spp. In order to evaluate the distribution of ISAba125, its occurrence was evaluated among 17 A. baumannii and 16 Acinetobacter species clinical isolates. These strains were negative for the bla NDM-1 gene, and some of them carried previously characterized resistance genes to Table 3 for references).
broad-spectrum ␤-lactams. ISAba125 was detected in 21 out of 33 strains (Table 2 ). In addition, the locations of 74 ISAba125 elements found in genomic sequences of 8 A. baumannii strains deposited in GenBank were mapped with respect to their target sites.
Half of the ISAba125 elements were located within ORFs. For 6 of them, the IRR of ISAba125, which provides a Ϫ35 box promoter element orientated toward the flanking DNA, was found in proximity (less than 100 bp) of the ATG start codon of the adjacent (15) . It could then transfer resistance genes to Enterobacteriaceae in the environment or in humans. The transposase directly influences the choice of the target site, with a preference for GC-or AT-rich DNA domains, local DNA structure, degree of supercoiling, replication or transcription level, and chromosome or plasmid location (10) . The target site of Tn125 was AT rich when the 3 bp surrounding the duplicated target site was considered, reaching 99% A and 96% T at positions Ϫ3 and ϩ3, respectively, and was enriched in GC within the 3-bp target site, which is duplicated upon transposition, with a strong preference for G at c3 (Fig. 2) . In A. baumannii clinical isolates, the same features are present in the chromosomal regions flanking the Tn125 and TnaphA6 composite transposons, the most recently identified being composed of the aphA6 aminoglycoside resistance gene surrounded by two ISAba125 elements (8, 21) . The preference for AT-rich regions, previously observed for ISAba1 (22) , is consistent with the Acinetobacter species origin of ISAba125, whose genome is AT rich (58 to 62%). The frequencies of transposition of Tn125 observed here were several orders of magnitude higher than, for example, those of the Tn2006 composite transposon and the ISAba1 and IS1999 elements (22, 23) ; unfortunately, these values are difficult to compare due to different experimental setups.
Two ISs were previously shown to be functional for transposition in A. baumannii, namely, ISAba825 (IS982 family) (24) and ISAba1 (IS4 family) (22, 25) . Here, we experimentally demonstrated the functionality of ISAba125 (IS30 family). Consistent with its ability to transpose, ISAba125 was described in association with increased resistance levels to ␤-lactams in Acinetobacter spp., for example, through duplication of the bla OXA-58 carbapenemase gene (26) , disruption of the carO gene encoding an outer membrane protein acting in synergy with other resistance mechanisms (27) , or insertion upstream of the bla ADC cephalosporinase gene (28) . In the sequenced genomes of strains listed in Table 3 , ISAba125 was found upstream of the ampC gene in strain ACICU (29) or flanking the aphA6 gene conferring resistance to amikacin in strain BJAB0715 (30) .
ISAba125 was present in more than half of the clinical isolates tested (Table 2 ). In a parallel study, analysis of 131 Acinetobacter spp. revealed that 5 strains had 1 copy, 34 strains had few (2 to 9) copies, 12 strains exhibited numerous (Ն10) copies, and 80 strains contained no copy of ISAba125 (31) . This high frequency and high copy number of ISAba125 in Acinetobacter spp. are indicative of frequent transposition events, lateral gene transfer within Acinetobacter spp., a replicative mechanism of transposition (as shown for the IS30 family), and the capacity of ISAba125 to expand within genomes, a general feature of ISs (9) . Taken together, these characteristics are suggestive of an evolutionary role of ISAba125 customized for Acinetobacter spp., as proposed for ISAba1 in A. baumannii (32, 33) .
This work demonstrates the ability of the bla NDM-1 -carrying Tn125 transposon to transpose in A. baumannii. It underlines the importance of A. baumannii, which has been considered for years as playing a minor role in medical microbiology. A. baumannii is likely in close contact in the environment with the (still unknown) natural progenitor of the bla NDM-1 gene and may play a key role in the spread of the bla NDM-1 gene to clinically relevant bacterial species, in particular members of the Enterobacteriaceae.
